Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 14.47%6.23B | 93.46%5.44B | -32.26%2.81B | -0.98%4.15B | 42.49%4.19B | 99.83%2.94B | -43.11%1.47B | 11.93%2.59B | -17.19%2.31B | 0.11%2.79B |
Net profit before non-cash adjustment | 23.94%4.87B | 9.91%3.93B | 27.93%3.57B | 6.48%2.79B | 8.33%2.62B | 50.28%2.42B | -16.58%1.61B | 0.66%1.93B | -1.83%1.92B | -5.72%1.95B |
Total adjustment of non-cash items | 2.36%1.34B | 5.04%1.31B | 7.20%1.25B | -19.81%1.17B | 19.17%1.45B | -5.35%1.22B | 111.13%1.29B | -42.96%610.56M | 31.85%1.07B | -2.61%811.75M |
-Depreciation and amortization | 6.57%2.19B | 9.84%2.05B | 20.33%1.87B | -0.64%1.55B | 9.99%1.56B | 3.31%1.42B | 3.98%1.38B | -6.02%1.32B | 8.39%1.41B | 19.61%1.3B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --157M | ---- | --70M | ---- | -90.67%26.37M | --282.66M | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,145.32%40.06M | -96.88%3.22M |
-Share of associates | -20.62%-544M | -21.24%-451M | -61.04%-372M | -16.67%-231M | -23.42%-198M | 19.26%-160.42M | 19.77%-198.68M | -31.99%-247.62M | 31.01%-187.6M | 16.30%-271.91M |
-Disposal profit | -24.36%-194M | 37.85%-156M | -13.06%-251M | -83.47%-222M | 0.25%-121M | -71.62%-121.3M | 71.55%-70.68M | -65.44%-248.46M | -189.39%-150.18M | -95.21%-51.9M |
-Net exchange gains and losses | 38.17%-81M | 21.56%-131M | -1,013.33%-167M | -126.79%-15M | 436.76%56M | -142.21%-16.63M | -34.22%39.39M | -35.79%59.89M | 148.87%93.28M | -93.47%-190.87M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.66%-500M | -69.10%-292.99M | ---173.27M |
-Other non-cash items | -766.67%-26M | -123.08%-3M | -83.75%13M | -3.61%80M | -13.99%83M | -16.98%96.5M | 294.59%116.23M | -137.53%-59.73M | -19.16%159.14M | 109.62%196.86M |
Changes in working capital | -93.53%13M | 110.01%201M | -1,129.74%-2.01B | 74.11%195M | 116.01%112M | 51.02%-699.51M | -3,211.37%-1.43B | 106.78%45.9M | -2,726.17%-676.95M | 121.90%25.78M |
-Change in receivables | -73.61%219M | 162.22%830M | -1,234.00%-1.33B | -134.01%-100M | 136.55%294M | 8.59%-804.3M | -76.66%-879.89M | -234.70%-498.06M | 166.68%369.76M | -35.63%-554.53M |
-Change in inventory | 636.21%311M | 63.29%-58M | -167.81%-158M | 3,228.57%233M | -80.02%7M | 110.62%35.04M | -276.06%-330M | 212.91%187.43M | -511.74%-166M | 164.53%40.32M |
-Change in payables | 57.72%-427M | -66.39%-1.01B | -81.74%-607M | 32.39%-334M | -143.53%-494M | 61.33%-202.85M | -268.43%-524.55M | 160.44%311.44M | -265.01%-515.3M | -73.85%312.29M |
-Provision for loans, leases and other losses | 124.35%75M | -115.38%-308M | -53.76%-143M | -138.46%-93M | 74.15%-39M | -10.65%-150.85M | -848.75%-136.33M | --18.21M | ---- | ---- |
-Changes in other current assets | -65.95%142M | -44.77%417M | 1,010.29%755M | 623.08%68M | -105.30%-13M | 556.53%245.13M | 89.79%-53.69M | 3.13%-525.99M | -27.71%-542.96M | 52.60%-425.17M |
-Changes in other current liabilities | -193.03%-307M | 163.34%330M | -223.75%-521M | 17.93%421M | 100.20%357M | -64.08%178.32M | -10.22%496.38M | 211.38%552.87M | -72.80%177.56M | 1,056.79%652.87M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -28.85%-201M | -0.65%-156M | 14.84%-155M | -2.82%-182M | 4.33%-177M | 4.98%-185M | 8.15%-194.69M | 12.49%-211.96M | 4.84%-242.22M | 2.12%-254.54M |
Interest received (cash flow from operating activities) | 53.33%598M | 38.79%390M | 83.66%281M | -79.16%153M | 408.52%734M | 68.99%144.34M | -48.63%85.41M | -15.69%166.28M | -7.05%197.23M | 100.68%212.18M |
Tax refund paid | 8.38%-1.08B | -30.07%-1.18B | -3.65%-908M | 7.20%-876M | -45.17%-944M | 18.11%-650.26M | -22.55%-794.07M | 4.32%-647.97M | 18.22%-677.26M | -8.12%-828.16M |
Other operating cash inflow (outflow) | -2M | 0 | 0 | -1M | 0 | -1K | 0 | 0.00%-1K | -1K | 0 |
Operating cash flow | 23.30%5.54B | 121.33%4.49B | -37.44%2.03B | -14.72%3.25B | 69.04%3.81B | 295.67%2.25B | -69.97%568.9M | 19.14%1.89B | -17.26%1.59B | 2.83%1.92B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 54.24%-324M | -34.86%-708M | -162.50%-525M | 83.25%-200M | -12.50%-1.19B | -33.52%-1.06B | 31.70%-794.86M | -568.50%-1.16B | 86.00%-174.08M | -95.18%-1.24B |
Net business purchase and sale | ---- | ---- | ---- | ---46M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 122.83%105M | -422.73%-460M | 46.01%-88M | 59.55%-163M | -51.97%-403M | 1.66%-265.18M | 18.85%-269.67M | -2,070.53%-332.31M | 113.14%16.86M | 26.45%-128.36M |
Net changes in other investments | ---- | ---1M | ---- | ---- | ---- | ---- | 50.00%-1K | -300.00%-2K | --1K | ---- |
Investing cash flow | 81.27%-219M | -90.70%-1.17B | -49.88%-613M | 74.39%-409M | -20.39%-1.6B | -24.61%-1.33B | 28.84%-1.06B | -851.58%-1.5B | 88.54%-157.22M | 40.30%-1.37B |
Financing cash flow | ||||||||||
Net issuance payments of debt | --0 | --0 | --0 | --0 | 56.56%-58M | -142.19%-133.52M | 338.86%316.44M | 47.32%-132.48M | -454.09%-251.49M | -93.11%71.03M |
Net common stock issuance | 23.89%-803M | -139.77%-1.06B | ---440M | ---- | ---- | ---61K | ---- | ---- | --557M | ---- |
Increase or decrease of lease financing | -13.74%-596M | -24.47%-524M | -65.75%-421M | -41.11%-254M | -95.85%-180M | 24.63%-91.91M | 17.09%-121.94M | -20.64%-147.07M | -79.25%-121.92M | -16.84%-68.02M |
Cash dividends paid | -62.85%-1.15B | -43.03%-708M | -0.20%-495M | -17.06%-494M | -29.45%-422M | -0.09%-326.01M | 0.05%-325.71M | 3.60%-325.86M | -7.75%-338.03M | -13.03%-313.71M |
Cash dividends for minorities | -14.23%-273M | -7.17%-239M | -24.58%-223M | -34.59%-179M | 7.16%-133M | 35.90%-143.25M | -282.18%-223.47M | 53.95%-58.47M | -84.94%-126.98M | -32.18%-68.66M |
Net other fund-raising expenses | 50.00%-1M | -100.00%-2M | 0.00%-1M | 0.00%-1M | -99,900.00%-1M | 0.00%-1K | 0.00%-1K | 50.00%-1K | 0.00%-2K | 33.33%-2K |
Financing cash flow | -11.79%-2.83B | -60.00%-2.53B | -70.26%-1.58B | -16.88%-928M | -14.29%-794M | -95.88%-694.75M | 46.57%-354.68M | -135.91%-663.89M | 25.82%-281.42M | -159.04%-379.36M |
Net cash flow | ||||||||||
Beginning cash position | 12.66%9.26B | 3.29%8.22B | 31.83%7.96B | 28.84%6.04B | 2.27%4.68B | -14.92%4.58B | -6.83%5.38B | 22.76%5.78B | 7.95%4.71B | 8.23%4.36B |
Current changes in cash | 213.44%2.5B | 588.34%796M | -108.54%-163M | 34.94%1.91B | 515.41%1.41B | 127.02%229.77M | -220.01%-850.32M | -123.08%-265.71M | 576.66%1.15B | -20.09%170.14M |
Effect of exchange rate changes | -10.61%219M | -42.22%245M | 3,161.54%424M | 120.97%13M | 50.51%-62M | -364.91%-125.29M | 136.69%47.3M | -60.54%-128.91M | -145.53%-80.3M | 48.88%176.37M |
Cash adjustments other than cash changes | ---- | -200.00%-1M | --1M | ---- | -99,900.00%-1M | ---1K | ---- | ---- | -200.00%-1K | --1K |
End cash Position | 29.32%11.97B | 12.66%9.26B | 3.29%8.22B | 31.83%7.96B | 28.83%6.04B | 2.28%4.68B | -14.92%4.58B | -6.83%5.38B | 22.76%5.78B | 7.95%4.71B |
Free cash flow | 38.91%4.96B | 178.84%3.57B | -53.45%1.28B | 14.29%2.75B | 152.44%2.41B | 334.65%953.9M | -232.10%-406.52M | -74.65%307.73M | 203.38%1.21B | -63.45%400.16M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |